conductance block of 77%. These blocking effects of The molecular effects of droperidol (C"H"FN,O,) on single sodium channels from the human brain were investigated using the electrophysiological planar lipid-bilayer technique. Droperidol (0.050.8 m~) induced a concentration dependent and voltage independent reduction in the time averaged single channel conductance by two mechanisms: a reduction droperidol on CNS sodium channels occurred at a concentration range comparable with other specific anaesthetic compounds but far beyond clinical serum levels (up to 0.002 m~) .
Summary
conductance block of 77%. These blocking effects of The molecular effects of droperidol (C"H"FN,O,) on single sodium channels from the human brain were investigated using the electrophysiological planar lipid-bilayer technique. Droperidol (0.050.8 m~) induced a concentration dependent and voltage independent reduction in the time averaged single channel conductance by two mechanisms: a reduction droperidol on CNS sodium channels occurred at a concentration range comparable with other specific anaesthetic compounds but far beyond clinical serum levels (up to 0.002 m~) .
Therefore in contrast with animal preparations (frog peripheral nerve, sodium channel) the human brain sodium channel is not a major target site for droperidol during clinical anin the fractional channel Open time (major effect, apaesthesia.
proximately 90%) and a decrease in the channel amplitude (minor effect). The weighted computer fit of the Keywords: DROPERIDOL, HUMAN BRAIN, SODIUM CHAN- concentration response for the combined effect curve NEL, LIPID BILAYER, VOLTAGE CLAMP, MOLECULAR MECHyielded an EC" of 0.68 m~ droperidol and a maximal ANISM. lntroduction Droperidol (C"HZ2FN3O,) is a butyrophenone related drug which is used clinically combined with a potent opioid to provide general (neurolept-) anaesthesia, as an efficient antiemetic drug andlar for the treatment of psychiatric disorders. The exact molecular mechanism(s) and site(s) of action of droperidol remain to be identified.
Existing studies demonstrated a significant droperidol mediated inhibition of dopamine DA-2, ctladrenergic and serotoninergic (5-HT") receptors within a nanomolar concentration range: receptorbinding studies on central dopamine DA-2 receptors showed an effective reduction of the dopamine uptake [I-31. Furthermore interactions between droperidol and al-adrenergic, serotoninergic (5-HT") and histamine receptors were demonstrated [3,41. A recent
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Correspondence: Dr C. Frenkel. patch-clamp study showed significant droperidol interactions (concentration range: 1 PM) with voltage activated sodiurn channels from the peripheral nerve [51. Peak serum concentrations during neuroleptanaesthesia average around 2 PM (proteinunbound: 0.3 PM), corresponding to 0.7 
Nevertheless, all these studies were performed on various animal but not on human preparations, and so far no information about droperidol's molecular mechanisms in a human in viv0 or in vitro preparation is available.
As part of our systematic investigation of molecular effects of intravenous (i.v.1 anaesthetically active substances, single sodium channels from human brain cortex, key componentsfor neuronal signal integration and transduction 181. were used in this study as human CNS model protein to quantify the molecular effects of.droperido1. Recently, we were able to show that hypnotics b g . propofol, pentobarbitone) depressed the sodium channel conductance in a dose range O 1998 European Academy of Anaesthesiology close t o clinically relevant concentrations [9-11 I. These effects occurred at concentrations predicted by the Meyer-Overton (anaesthetic potency vs. lipophilicity) correlation and indicated a lipophilic site of action for these substances. By contrast, more specific drugs used in anaesthesia (e.g. benzodiazepines, opioids) did not affect sodium channels at clinically relevant concentrations I.
It is of interest, therefore, t o establish the EC" value and the concentration range at which droperidol -a specific inhibitor of central receptors isee above) -affects the 'human' CNS sodium channel. The EC, value will be compared with clinically relevant cuncentrations of droperidol anb it will be tested whether the EC" value follows the Meyer-Overton correlation. This study has been presented in abstract form [12] .
Methods
Electrophysiological bilayer experiments were carried out as previously described 19,13,141. A short summary is given here. Before the study was initiated approval of the institutional ethic committees was given (Committee on human rights i n research, Cornell University Medical College, New York, NY, USA and Ethic's Committee of the Medical Faculty, University of Bonn, Germany).
All experiments were performed i n symmetrical, 500 m M NaCl buffered at pH 7.4 with 10 mrvi HEPES, at room temperature. Planar Iipid bilayers were formed from neutral phospholipid solutions, containing synthetic (4:l) phosphatidylethanolamine and phosphatidylcholine in decane. Samples of human brain cortex were obtained from neurosurgical waste, material was never removed for the purpose of this study alone. Synaptosomal fractions were prepared from the cortex tissue as described before 19,151: biological membranes can be broken up in such a way that the remaining fragments reseal to form small membrane vesicles containing sodium channels. These membrane vesicles were added t o the vicinity of the lipid bilayers with micropipets in such a way that through a spontaneous process of membrane fusion the sodium channels were transferred from the vesicle into the planar lipid bilayer.
After channel incorporation membrane potentials were applied across the bilayer and the resulting ioncurrent was measured using an experimental Set-up described in Fig. 1 [131. ldentification and steady-state measurements of sodium channels were carried out i n the presence of the sodium channel maker and activator batrachotoxin [161. The alkaloid-toxin batrachotoxin is commonly used in bilayer experiments removing channel inactivation and increasing channel opening time. Control measurements of the incorporated channels included measurements of the fractional Open time, the single channel arnpfitude and conductance as well as the steady-state activation behaviour. Forthe measurement of the fractional Open times, current traces were recorded by the Computer, time-averaged and, after subtraction of the membrane capacitive transient, converted into conductances. The fractional Open time, f" was obtained by subtracting the background conductance through the Iipid bilayer from the averaged conductance and divided by the number of channels and the single channel conductance [l31. The steady-state activation behaviour was obtained by plotting a series of fractional Open times from potential sequences as a function of the applied membrane potential. Subsequently, these fractional Open times were fitted t o a two-level Boltzmann distribution by a least Squares fitting procedure. The fractional Open time, plotted as a continuous function of membrane potential, is referred to as the steady-state activation curve.
After completion of the control measurements, increasing concentrations of droperidol (Janssen Pharmaceuticals, Neuss, Germany: clinical formulation; 0.05-0.8 m~) were added t o the intra-or extracellular compartment and the Same measurements repeated.
The literature provides contradictory information about the maximal solubility of pure droperidol in aqueous solutions (water, 25°C) ranging from 0.01 m g m L -' or 0 . 0 2 6 m~[ 1 7 1 t o 0.1 m g m L -' or 0.26 mM 1181. In order t o reach higher concentrations, the clinical formulation of droperidol (containing the solubilizer: tartatric acid and manitol) was used in our experiments. To ensure a full solubilization of droperidol in our study, special experiments measuring the rate of sedimentation/precipitation were performed (ZETAPIus, Brockhaven Instruments, Holtsville USA). These measurements revealed that up t o a final droperidol concentration of 1.65 mM no significant increase in the number of complex particles and no precipitation could be observed within the first 150min. This is in line with results obtained by Droperidol actions o n h u m a n CNS ion channels 91 Teflon chamber Fig. 1 . Schematic of the experimental arrangement. A thin teflon partition separates two electrolyte chambers, each containing a silver chloride electrode. The teflon partition is perforated by a hole of 0.3 mm (diameter exaggerated in drawing) across which the lipid bilayer is formed. The sodium channel preparation is added to one of the bilayer chambers. The membrane can be viewed with a microscope through a glass window in the front bilayer chamber. The membrane potential is controlled through the DAC output of the interface which is connected to an experimental computer. The other electrode records membrane currents with the aid of a current-to-voltage converter, the output of which is further amplified and filtered. The resulting signal can be viewed on an osciltoscope snd a chart recorder, but it is als6 sent to the ADC port of the interface, digitized and stored for a subsequent analysis.
Janssen laboratories: no precipitation of 2.64 mM droperidol (0.9% NaCl solution, pH 7.4, 25°C) within 12 h [171.
Results
A total of 12 membranes containing 30 channels (range: 1-5, average 2.5f 1.7 channels per membrane) were studied using our Standard voltage-clamp protocol (see methods). The investigated channels were identified as sodium channels by tetrodotoxin block, sodium selectivity and reproducible single channel characteristics. The channels were monitored for 31.6t 16.0 min (mean f CD) under control conditions before various concentrations of droperidol (0.05-0.8 m~) were added. Control measurements revealed a reproducible channel behaviour in line with previous studies using batrachotoxin modified sodium channels from human brain Cortex [9, 13] .
The fractional Open time (f,) of the channels under control conditions was 0.97 f 0.4 (CD), with an average single channel slope conductance of 23.6k3.7 pS (CD) within a membrane potential range between +_45 mV. The channels showed increasing closing events with hyperpolarizing membrane potentials resulting i n a steady-state activation midpoint potential (V,) of -97f12 mV (meanfSEM, n=4 membranes, 9 channels) and an effective gating charge (z,) of 2.7k2.5 (CD).
After addition of various concentrations of droperidol the number and duration of channel closing events significantly increased (Fig. 2) . This was the main effect and accounted for about 90% of the overall sodium conductance block. A minor effect resulted in a decrease in the channel amplitude. This current suppression was quantified by time averaging the current traces. Time-averaged conductances were plotted vs. the applied membrane potential and proved t o be independent between f 45 mV (Fig. 3) .
The overall blocking effect of sodium channel conductance was plotted vs. increasing droperidol concentrations and then fitted by a weighted computer fit. The resulting concentration-response curve (Fig.  4a) could be approximated by a rectangular hyperbola, yielding a maximal conductance block of 77%, a halfmaximal blocking concentration (E&) of 0.68 m M and an EC, , , of 0.08 mM.
As the time-averaged channel conductance block consisted of two distinct mechanisms, the fractional opening time block and the reduction in the channel amplitude were analysed separately. Each effect showed a dependence on droperidol concentration and could also be computer fitted yielding t w o different concentration-response curves with a maximum block of the fractional Open time of 69% (EC": 0 . 7 l ' m~, Fig. 4b ) and 20% for the channel amplitude block (EC": 1.28 mm, Fig. 4c) .
Furthermore droperidol reduced the time during which the channel could be observed: 0.05 m~ droDiscussion peridol 24.5f 5.0 mln (mean +SD); 0.4 mM droperidol This initial study of the molecular effects of droperidol 4 . 5 5 2 . 5 min. The steady-state-activation behaviour of ,human, CNs ion channel two significant the investigated sodium channels did not change sigarid substance-specific interactions with the ion connificantly with droperidol exposure. The average closducting pathway of the protein, ing midpoint potential under control conditions was ~~~~~~i , -~~l reduced the time averaged s o~i u m m~asured to be -98* l0 mV (mean+SEMl 3 memchannel conductance in a concentration-dependent branes Per 3 channels)-In the Presence of 0.1 mM and voltage independent manner: the maximal condroperidol the average midpoint potential was' ductance block was calculated to be 77% with a half--104'5 mV for the Same (control) channels, not sig- on channel amplitude [9,111, while the hypnotic etoThese distinct effects of channel block by droperidol midate and the alcohol ethanol primarily blocked chan-nel conductance via a reduction in the single-channel amplitude [19, 20] . Furthermore, high droperidol concentrations ( > 0 . 2 m~) reduced the time that sodium channels could be observed in the bilayer as compared with low concentration conditions in a concentration-dependent manner (0.05 mM droperidol: mean 24.5 min; 0.4 mM: mean 4.5 min). This may indicate a droperidolinduced interaction at/with the batrachotoxin binding site of the channel or a drug-induced change i n the channel quaternary structure.
These effects occurred at concentrations 100-fold beyond relevant Serum concentrations (max. 2 p~, protein unbound 0.3 PM) during general anaesthesia 171. Thus, the human brain sodium channel is unlikely t o be a major relevant molecular target for pharmacological actions of droperidol in humans.
Interestingly, the human CNS sodium channels i n this study proved t o be far more insensitive t o droperidol (EC": 0.68 m~) than peripheral nerve sodium channels from a frog (node of Ranvier) preparation (1.4 IIM) [51. Thus, anaesthetic potency may be species or tissue dependent, which makes the use of human protein preparations mandatory whenever comparative pharmacological studies in humans are proposed.
It has t o be taken into consideration that planar bilayer studies of sodium channels still rely on the presence of alkaloid toxins. The extent t o which anaesthetic actions are altered in the presence of batrachotoxin [I61 has been discussed before [91. Nevertheless, batrachotoxin is a unique marker for labelling an individual sodium channel, allowing long observations of channel behaviour of the Same, identified single channel.
The established correlation between lipophilicity and anaesthetic potency for several substances used for clinical anaesthesia (Meyer-Overton correlation) suggests a lipophilic mode of action for these substances [ I 1,211. Assuming a partition coefficient o f 3100 for the pure substance [I71 and postulating mainly lipophilic interactions between droperidol and the human brain sodium channel as a site or mechanism of molecular action, an effect concentration of about 0.1 mM should be expected [221. Droperidol reduced sodium channel conductance with an ECSo of 0.68 mM and an EClo of 0.08 mM. Thus, the EC" value is clearly beyond the predicted (Meyer-Overton) concentrations. The partition coefficient of droperidol in the clinical formulation will have to be smaller than for the pure substance. Because its actual value is unknown it is not possible t o decide whether droperidol with a corrected value of the partition coefficient would still be outside the Meyer-Overton correlation.
One critical factor in the discussion of these results is the absolute solubility of droperidol in this system. Contradicting information for the solubility of pure droperidol (water, 25°C) range from 0.01 m g mL-' or 0.026 mM [I71 t o 0.1 m g m L -T or 0.26 mM [18] , but at these measurements (see material and methods) for the rate sedimentation of the clinical formulation of droperidol (with solvents: tartatric acid and manitol) no precipitation could be observed. Thus, effective droperidol concentrations of up t o 0.8 mM were actually achieved in our system. Thus, we conclude: (1) droperidol depresses the human CNS sodium channel with distinct effects but only at high concentrations; (2) at least partly a lipophilic mode of action in this model protein is possible and (3) human CNS sodium channels do not serve as a relevant target protein for droperidol clinical effects, which are more likely mediated by specific interactions with central (dopamine, adrenergic and serotonin) receptors.
